Description of a novel mutation leading to MYH9-related disease.

[1]  H. Saito,et al.  Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders , 2008, European journal of haematology.

[2]  H. Saito,et al.  Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders. , 2008, Blood.

[3]  P. Noris,et al.  Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease , 2008, Human mutation.

[4]  H. Kanegane,et al.  Identification of a novel MYH9 mutation in a patient with May‐Hegglin anomaly , 2006, Pediatric blood & cancer.

[5]  L. Camoin,et al.  Le syndrome MYH9 : à propos d'une nouvelle observation et de la mise en évidence d'une nouvelle mutation du gène MYH9 , 2006 .

[6]  E. Ma,et al.  Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family. , 2006, Haematologica.

[7]  R. Ravazzolo,et al.  MYH9-Related Disease: May-Hegglin Anomaly, Sebastian Syndrome, Fechtner Syndrome, and Epstein Syndrome Are not Distinct Entities but Represent a Variable Expression of a Single Illness , 2003, Medicine.

[8]  H. Saito,et al.  Immunofluorescence Analysis of Neutrophil Nonmuscle Myosin Heavy Chain-A in MYH9 Disorders: Association of Subcellular Localization with MYH9 Mutations , 2003, Laboratory Investigation.

[9]  Corinne Antignac,et al.  Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. , 2002, Journal of the American Society of Nephrology : JASN.

[10]  H. Saito,et al.  Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions , 2001, Journal of Human Genetics.

[11]  J. White,et al.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. , 2001, American journal of human genetics.

[12]  Toshihiro Tanaka,et al.  Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). , 2001, Blood.

[13]  M. Kelley,et al.  Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. , 2000, American journal of human genetics.

[14]  U Magrini,et al.  Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. , 2000, Nature genetics.

[15]  T. Ortel,et al.  Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly , 2000, Nature Genetics.